|Videos|May 29, 2020

NCCN Recommendations: Frontline CLL Treatment Options

Episodes in this series

Now Playing

EP. 1 NCCN Recommendations: Frontline CLL Treatment Options

EP. 2 Front-Line Therapy Decision Criteria

EP. 3 Limited-Duration Therapy Based on MRD Testing

EP. 4 Newly Diagnosed CLL: BTK Inhibitor Monotherapy

EP. 5 Developing Clinical Trials for Newly Diagnosed Disease

EP. 6 First-Line Therapy for Treatment-Naïve Patients

EP. 7 BTK Inhibitor Toxicity Management

EP. 8 Oral Oncolytics Versus Intravenous: Safety and Efficacy

EP. 9 Oral Therapy Adverse Events

EP. 10 Intravenous Versus Oral Delivery: Medical Benefits

EP. 11 Pharmacy-Led Oral Chemotherapy Management Programs

EP. 12 Optimizing Success for Community Physicians

EP. 13 Experts Outline Best Practices in the Treatment of Chronic Lymphocytic Leukemia

EP. 14 Experts Discuss Treatment Considerations for Chronic Lymphocytic Leukemia

In this Directions in Oncology Pharmacy Insights video series, Alison Duffy, PharmD, BCOP, University of Maryland School of Pharmacy, and Cody Steeves, PharmD, BCOP, Biologics by McKesson, discuss advancements and updates in therapies for chronic lymphocytic leukemia (CLL). This first segment focuses on NCCN recommendations for frontline treatment options.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Online Article

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

1.0 Credit / Law

On-Demand Virtual Symposium

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

1.5 Credits / Psychiatry

On-Demand Virtual Symposium

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

1.0 Credit

NCCN Recommendations: Frontline CLL Treatment Options

Episodes in this series

EP. 1 NCCN Recommendations: Frontline CLL Treatment Options

EP. 2 Front-Line Therapy Decision Criteria

EP. 3 Limited-Duration Therapy Based on MRD Testing

EP. 4 Newly Diagnosed CLL: BTK Inhibitor Monotherapy

EP. 5 Developing Clinical Trials for Newly Diagnosed Disease

EP. 6 First-Line Therapy for Treatment-Naïve Patients

EP. 7 BTK Inhibitor Toxicity Management

EP. 8 Oral Oncolytics Versus Intravenous: Safety and Efficacy

EP. 9 Oral Therapy Adverse Events

EP. 10 Intravenous Versus Oral Delivery: Medical Benefits

EP. 11 Pharmacy-Led Oral Chemotherapy Management Programs

EP. 12 Optimizing Success for Community Physicians

EP. 13 Experts Outline Best Practices in the Treatment of Chronic Lymphocytic Leukemia

EP. 14 Experts Discuss Treatment Considerations for Chronic Lymphocytic Leukemia

Related Content

Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials

Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer

Iberdomide-Based Quadruplet Induction Followed by Maintenance Achieves High Response and MRD Negativity in NDMM

Teclistamab Monotherapy Demonstrates Significant Survival and Response Benefits Versus Standard Regimens in RRMM

The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means

Latest CME

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Directions in Pharmacy 2026

New and Emerging Therapies for the Management of Narcolepsy: A Guide to Patient-Centered Care

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Iron Deficiency Anemia Treatment Considerations in Women’s Health

Neuropsychiatry Day of Education 2026

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Cardiology Day of Education 2026

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights (Pharmacy Technician Credit)

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Immunology Specialty Pharmacy Day of Education 2026

Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages

Oncology Pharmacists Connect 2026

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond

Breast Cancer Day of Education 2026

Neuropsychiatry Day of Education 2026

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Evolving Care: Treating Demodex Blepharitis for Pharmacists

Immunology Specialty Pharmacy Day of Education 2026

Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter

Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy

Cardiology Day of Education 2026

Redefining Metabolic Dysfunction-Associated Steatohepatitis Treatment: Managed Care Insights on New Therapies Targeting Metabolic Dysfunction

Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC

From Molecule to Medication: Integrating Menin Inhibitors in AML Practice

Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances

Breast Cancer Day of Education 2026